Letter to The Lancet, signed by (among others) the two scientists who just resigned from FDA, advises AGAINST “boosters”

“Current evidence does not, therefore, appear to show a need for boosting in the general population, in which efficacy against severe disease remains high.”


PDF [230 KB]

Considerations in boosting COVID-19 vaccine immune responses
Philip R Krause, MD

Prof Thomas R Fleming, PhD

Prof Richard Peto, FRS

Prof Ira M Longini, PhD

Prof J Peter Figueroa, PhD

Prof Jonathan A C Sterne, PhD

et al.
Show all authors

Published:September 13, 2021DOI:

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.